shannon faught

Chief Commercial Officer in the Pharmaceutical Industry

[Congresswoman Beth Van Duyne @RepBethVanDuyne]

Great to see Alora Pharmaceuticals on Wednesday, we discussed the latest in my efforts in urging the U.S. Food and Drug Administration (FDA) to protect access to Desiccated Thyroid Extract (DTE). Patients rely on this treatment every day, and I'll continue pushing to make sure they don't lose it.

[Acella Pharmaceuticals @AcellaPharma]

If your insurance uses CVS Caremark & you rely on DTEs, here’s what you can do:

- Call 1-888-217-4161 for plan details
- Ask your provider to submit a Prior Authorization
- Explore cash-pay & savings options

Clear information helps you make confident decisions about your care.

[Acella Pharmaceuticals @AcellaPharma]

CVS Caremark is removing DTE medications from its coverage, but they remain widely available.

If you’re not covered after April 1, you still have options.
- Ask about a Prior Authorization
- Contact CVS Caremark at 1-888-217-4161
- Check pricing on GoodRx or Optum Perks

[shannon faught @shannonfaught]

@Rainmaker1973 Spa

[Acella Pharmaceuticals @AcellaPharma]

To clarify recent confusion: DTEs remain available nationwide.

If your plan has been affected by the recent CVS Caremark change in coverage:
- Call 1-888-217-4161 for plan details
- Explore savings options including Glendale Pharmacy

You deserve continuity in care.

[Cam Erickson @camerickson]

Not a bad way to spend my birthday — watching @AbrahamHamadeh deliver a win for 1.5 million patients who almost lost access to their thyroid medications because of one conflicted bureaucrat.
FDA backed down. Meds stay on the shelves. That's the whole story.
🔗 https://t.co/H3HrWdThdI

[Acella Pharmaceuticals @AcellaPharma]

We thank Dr. Makary and the FDA for your leadership in protecting access to DTEs for the 1.5M Americans who depend on this vital medication every day.

We look forward to continuing our work in pursuit of full FDA approval.

https://t.co/u2pMcUQMKu

[Graves' Disease & Thyroid Foundation @GDATF]

🚨 NEW! This update from the FDA replaces the 12-month doomsday deadline on #DTE with an announcement that "draft guidance" will be prepared. Good news for patients! But would this have affected the CVS/Caremark decision to remove DTE from its formulary had it come sooner?

[Acella Pharmaceuticals @AcellaPharma]

ATA underscores the importance of treatment choice for people with hypothyroidism.

ATA Statement: https://t.co/wCdYwbcYdm

#ThyroidHealth

[Acella Pharmaceuticals @AcellaPharma]

We are proof that innovation in healthcare is thriving.

U.S. innovation delivers thyroid care with #DTEs.

#ThyroidHealth

[Acella Pharmaceuticals @AcellaPharma]

More than 1.5 million Americans rely on DTE therapies, and many say it’s the treatment that they prefer.
#ThyroidHealth

[Acella Pharmaceuticals @AcellaPharma]

#DTEs have been trusted for 100+ years.
Patients deserve uninterrupted access to the medicine that they rely on.
Read more: https://t.co/pMBFWgAC3g

#ThyroidHealth #DTEs

[shannon faught @shannonfaught]

@Sadie_NC Helmans

[Acella Pharmaceuticals @AcellaPharma]

More than 1.5 million Americans with hypothyroidism rely on DTE therapies. For many, it’s the treatment that works best for them. Taking DTEs away could harm American patients who have already failed on other therapies. Our CEO Art Deas explains more here: https://t.co/pMBFWgB9SO

[Acella Pharmaceuticals @AcellaPharma]

Thank you @RepBethVanDuyne for helping ensure that 1.5 million Americans continue to have access to the medicine that works best for them. DTEs are a vital treatment option for Americans with hypothyroidism.

[American Thyroid Association @AmThyroidAssn]

American Thyroid Association Statement on Desiccated Thyroid Extract (#DTC)

Read full article: https://t.co/zvAog7LP3z

#DTC #FDA #levothyroxine #Hypothyroidism #Thyroid @thyroidjournal @clinicalthyroid

[Graves' Disease & Thyroid Foundation @GDATF]

This is a different disease state, but illustrates the FDA approval process can be non-linear! @US_FDA needs to clarify whether its 8/7 announcement on #DTE for hypothyroidism has been officially rescinded. If not, when does the 12-month transition start? https://t.co/qawXzoIRPL

[Graves' Disease & Thyroid Foundation @GDATF]

Found this update on the product FAQ page for Acella Pharmaceuticals. Excerpt: "We will be working with the FDA to reexamine their position and ensure that DTEs, including NP Thyroid®, remain available to the 1.5 million U.S. patients who rely on them." https://t.co/5IlNaJwauq

[Office of Congressman Abe Hamadeh @RepAbeHamadeh]

Arizona’s 8th Congressional District has a significant veteran & senior population who depend on consistent access to thyroid medications

Any disruption to their treatment regimens could have serious health consequences

The Congressman is seeking answers
https://t.co/98kBihEwC3

[Acella Pharmaceuticals @AcellaPharma]

We strongly agree with @DrMakaryFDA that patient access to desiccated thyroid extracts like NP Thyroid must be protected! Our subsidiary company Neuvosyn will continue to work with the @FDA to gain approval of our DTE product with a gold-standard approach. #MAHA #Thyroidpatients @SecKennedy